During the past decade, Sydney Local Health District conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sydney Local Health District" are "Amyotrophic Lateral Sclerosis" (1 trials), "Graft vs Host Disease" (1 trials), "Muscular Dystrophies" (1 trials), "Neurologic Disorder" (1 trials) and "Paralysis" (1 trials). Many other conditions were trialed in "Sydney Local Health District" in a lesser frequency.

Most popular intervention types in "Sydney Local Health District" are "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Mesenchymoangioblast-derived mesenchymal stem cells" (1 trials) and "Motor Neuroprosthesis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sydney Local Health District" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sydney Local Health District". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sydney Local Health District, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sydney Local Health District, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".